The global blood products market is experiencing steady growth owing to increasing demand for blood-derived therapies, rising prevalence of hematological disorders, growing surgical procedures, and continuous advancements in blood collection and processing technologies.

According to Straits Research, the global blood products market size was valued at USD 38.79 billion in 2025 and is projected to grow from USD 40.54 billion in 2026 to USD 57.65 billion by 2034, registering a CAGR of 4.5% during the forecast period (2026-2034).

Key Highlights

• Market Size (2025): USD 38.79 Billion
• Market Size (2026): USD 40.54 Billion
• Forecast Market Size (2034): USD 57.65 Billion
• CAGR (2026-2034): 4.5%
• Base Year: 2025
• Forecast Period: 2026-2034
• Largest Region: North America
• Fastest Growing Region: Asia-Pacific
• Largest Product Type Segment: Plasma
• Fastest Growing Product Type Segment: Immunoglobulins
• Largest Application Segment: Surgical Procedures
• Fastest Growing Application Segment: Cancer Treatment
• Largest End-User Segment: Hospitals
• Fastest Growing End-User Segment: Ambulatory Surgical Centers

Market Dynamics

Market Driver

The increasing incidence of chronic diseases, blood disorders, cancer, trauma injuries, and surgical procedures is significantly driving demand for blood products worldwide. Components such as plasma, platelets, red blood cells, albumin, coagulation factors, and immunoglobulins are increasingly utilized in treating anemia, hemophilia, immunodeficiency diseases, and various oncological conditions. Growing awareness regarding blood donation and improved healthcare infrastructure are further supporting market growth.

Additionally, advancements in blood processing technologies, enhanced screening procedures, and increasing investments in healthcare systems are improving the safety and availability of blood products. Rising demand for plasma-derived therapies and expanding applications of immunoglobulins continue to strengthen market expansion.

Market Restraint

Despite favorable growth prospects, the market faces challenges associated with the high cost of blood collection, storage, testing, and processing. Maintaining stringent safety standards and preventing contamination require sophisticated infrastructure and specialized personnel, increasing operational expenses for healthcare facilities and blood banks.

Furthermore, limited blood donations, supply shortages, and regulatory complexities surrounding blood product manufacturing and distribution may hinder market growth, particularly across developing regions.

Market Opportunity

Growing adoption of advanced plasma fractionation technologies and increasing investments in biotechnology are creating substantial opportunities for industry participants. Emerging economies are witnessing rapid healthcare development and increased awareness regarding blood-related treatments, opening new avenues for market expansion.

Moreover, ongoing research focused on recombinant therapies, stem-cell-based products, and innovative blood substitutes is expected to provide lucrative growth opportunities during the forecast period. Expansion of blood banking networks and improvements in cold-chain logistics are also anticipated to enhance product accessibility globally.

Top Market Players

• CSL Limited
• Grifols S.A.
• Baxter International Inc.
• Takeda Pharmaceutical Company Limited
• Octapharma AG
• Bio-Rad Laboratories, Inc.
• Haemonetics Corporation
• LFB Group
• Macopharma
• Terumo Corporation

Market Segmentation

By Product Type

• Whole Blood
• Red Blood Cells (RBCs)
• White Blood Cells
• Platelets
• Plasma
  • Fresh Frozen Plasma (FFP)
  • Immunoglobulins
  • Albumin
  • Coagulation Factors
• Others

By Application

• Anemia
• Hemophilia
• Surgical Procedures
• Trauma and Accident Care
• Cancer Treatment
• Immunodeficiency Diseases
• Others

By End User

• Hospitals
• Blood Banks
• Diagnostic Laboratories
• Ambulatory Surgical Centers
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Middle East & Africa
• Latin America

Unlock Full Report Insights and Strategic Analysis: https://straitsresearch.com/report/blood-products-market

The report provides comprehensive insights into market trends, competitive landscape, growth drivers, emerging opportunities, regulatory frameworks, and strategic developments shaping the global blood products industry through 2034.

About Us

Straits Research is a leading market research and market intelligence organization specializing in research, analytics, and advisory services while providing actionable business insights and detailed market research reports across diverse industries.

Contact Us

Email: sales@straitsresearch.com

U.S.: +1 646 905 0080

U.K.: +44 203 695 0070